Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway

Wei Li; Wei Sun; Chuan-hua Yang; Hong-zhen Hu; Yue-hua Jiang

doi:10.1007/s11655-013-1380-3

Your Location：

Home >

Browse articles >

Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway

OriginalPaper | Updated：2021-08-27

- Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway
- Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway
- 中国结合医学杂志（英文版） 2014年20卷第3期页码：216-223
- Affiliations：
  
  1. Nanjing University of Chinese Medicine,Nanjing,China
  2. Jiangsu Province Hospital of Traditional Chinese Medicine,Nanjing,China
  3. Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan,China
- Author bio：
- Funds：
  
  Supported by Science and Technology Development Plan of Shandong Province (No. 2012G0021837)
- DOI：10.1007/s11655-013-1380-3
  中图分类号：
- 纸质出版日期：2014，
  
  网络出版日期：2014-3-4，
Scan for full text
Li, W., Sun, W., Yang, Ch. et al. Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway., Chin. J. Integr. Med. 20, 216–223 (2014). https://doi.org/10.1007/s11655-013-1380-3

Wei Li, Wei Sun, Chuan-hua Yang, et al. Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway[J]. Chinese Journal of Integrative Medicine, 2014,20(3):216-223.
Li, W., Sun, W., Yang, Ch. et al. Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway., Chin. J. Integr. Med. 20, 216–223 (2014). https://doi.org/10.1007/s11655-013-1380-3 DOI：

Wei Li, Wei Sun, Chuan-hua Yang, et al. Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway[J]. Chinese Journal of Integrative Medicine, 2014,20(3):216-223. DOI： 10.1007/s11655-013-1380-3.

摘要

To test whether tanshinone II A (Tan II A)

a highly valued herb derivative to treat vascular diseases in Chinese medicine

could protect endothelial cells from bacterial endotoxin (lipopolysaccharides

LPS)-induced endothelial injury. Endothelial cell injury was induced by treating human umbilical vein endothelial cells (HUVECs) with 0.2 μg/mL LPS for 24 h. Y27632 and valsartan were used as positive controls. The effects of tanshinone II A on the LPS-induced cell viability and apoptosis rate of HUVECs were tested by flow cytometry

cell migration by transwell

adhesion by a 96-well plate pre-coated with vitronectin and cytoskeleton reorganization by immunofluorescence assay. Rho/Rho kinase (ROCK) pathwayassociated gene and protein expression were examined by microarray assay; quantitative real-time polymerase chain reaction and Western blotting were used to confirm the changes observed by microarray. Tan II A improved cell viability

suppressed apoptosis and protected cells from LPS-induced reductions in cell migration and adhesion at a comparable magnitude to that of Y27632 and valsartan. Tan II A

Y27632 and valsartan also normalized LPS-induced actomyosin contraction and vinculin protein aggregation. A microarray assay revealed increased levels of fibronectin

integrin A5 (ITG A5)

Ras homolog gene family member A (RhoA)

myosin light chain phosphatase

phosphatidylinositol-4

5-bisphosphate 3-kinase (PI3K

or PIP2 in Western blotting)

focal adhesion kinase

vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in the damaged HUVECs

which were attenuated to different degrees by Tan II A

Y27632 and valsartan. Conclusion: Tan II A exerted a strong protective effect on HUVECs

and the mechanism was caused

at least in part

by a blockade in the Rho/ROCK pathway

presumably through the down-regulation of ITG A5.

Abstract

To test whether tanshinone II A (Tan II A)

a highly valued herb derivative to treat vascular diseases in Chinese medicine

could protect endothelial cells from bacterial endotoxin (lipopolysaccharides

cell migration by transwell

suppressed apoptosis and protected cells from LPS-induced reductions in cell migration and adhesion at a comparable magnitude to that of Y27632 and valsartan. Tan II A

Y27632 and valsartan also normalized LPS-induced actomyosin contraction and vinculin protein aggregation. A microarray assay revealed increased levels of fibronectin

integrin A5 (ITG A5)

Ras homolog gene family member A (RhoA)

myosin light chain phosphatase

phosphatidylinositol-4

5-bisphosphate 3-kinase (PI3K

or PIP2 in Western blotting)

focal adhesion kinase

vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in the damaged HUVECs

which were attenuated to different degrees by Tan II A

Y27632 and valsartan. Conclusion: Tan II A exerted a strong protective effect on HUVECs

and the mechanism was caused

at least in part

by a blockade in the Rho/ROCK pathway

presumably through the down-regulation of ITG A5.

关键词

tanshinone II Ahuman umbilical vein endothelial cellsRho/Rho kinase pathway

Keywords

tanshinone II Ahuman umbilical vein endothelial cellsRho/Rho kinase pathway

references

Okamura N, Saito M, Mori A, Sakamoto K, Kametaka S, Nakahara T, et al. Vasodilator effects of fasudil, a Rho-kinase inhibitor, on retinal arte-rioles in stroke-prone spontaneously hypertensive rats. J Ocul Pharmacol Ther 2007;23:207–212.

Heng XP, Chen KJ, Hong ZF, He WD, Chu KD, Chen WL, et al. Anticolchicine cytotoxicity enhanced by Dan Gua- Fang, a Chinese herb prescription in ECV304 in mediums. Chin J Integr Med 2011;17:126–133.

Kim SB, Kang OH, Keum JH, Mun SH, Seo YS, Choi JG, et al. Anti-inflammatory effects of Danggui Liuhuang Decoction in RAW 264.7 cells. Chin J Integr Med 2012; Dec 3 [Epub ahead of print]

Ishikawa Y, Nishikimi T, Akimoto K, Ishimura K, Ono H, Matsuoka H. Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats. Hypertension 2006;47:1075–1083.

Fish JM, Welchons DR, Kim YS, Lee SH, Ho WK, Antzelevitch C. Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome. Circulation 2006;13:1393–1400.

Yin X, Yin Y, Cao FL, Chen YF, Peng Y, Hou WG, et al. Tanshinone IIA attenuates the inflammatory response and apoptosis after traumatic injury of the spinal cord in adult rats. PLoS One 2012;7:e38381.

Liu F, Yu G, Wang G, Liu H, Wu X, Wang Q, et al. An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancer. PLoS One 2012;7:e42138.

Bateman HR, Liang QL, Fan DP, Rodriguez V. Lessner SM. Sparstolonin B inhibits pro-angiogenic functions and blocks cell cycle progression in endothelial cells. PLoS One 2013;8:e70500.

Clapp C, Thebault S, Jeziorski MC, Martinez De La, Escalera G. Peptide hormone regulation of angiogenesis. Physiol Rev 2009;89:1177–1215.

De Luisi A, Ferrucci A, Coluccia AM, Ria R, Moschetla M, et al. Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma. Clin Cancer Res 2011;17:1935–1946.

Pannekoek WJ, Kooistra MR, Zwartkruis FJ, Bos JL. Cellcell junction formation: the role of Rap1 and Rap1 guanine nucleotide exchange factors. Biochim Biophys Acta 2009;1788:790–796.

Takase H, Matsumoto K, Yamadera R, Kubota Y, Otsu A, Suzuki R, et al. Genome-wide identification of endothelial cell-enriched genes in the mouse embryo. Blood 2012;120:914–923.

Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001;410:37–40.

Yamamoto K, Hamada H, Shinkai H, Kohno Y, Koseki H, Aoe T. The KDEL receptor modulates the endoplasmic reticulum stress response through mitogen-activated protein kinase signaling cascades. J Biol Chem 2003;278:34525–34532.

Kitamura T, Asai N, Enomoto A, Maeda K, Kato T, Ishida M, et al. Regulation of VEGF-mediated angiogenesis by the AKT/PKB substrate girdin. Nat Cell Biol 2008;10:329–337.

Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006;86:279–367.

Ronty M, Taivainen A, Moza M, Kruh GD, Ehler E, Carpen O. Involvement ofpalladin and alpha-actinin in targeting of the Abl/Arg kinase adaptor ArgBP2 to the actin cytoskeleton. Exp Cell Res 2005;310:88–98.

Romer LH, Birukov KG, Garcia JG. Focal adhesions paradigm for a signaling nexus. Circ Res 2006;3:606–616.

Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 2009;15:177–184.

Shi Y, Li XY, Wang TY, Chang D, Zheng L, Wang SL. Pharmacokinetics and pharmacodynamics studies of tanshinone IIA and tanshinone IIA sulfonate. Chin J Pharmaceutics (Chin) 2009;7:143–153.

Van Nieuw Amerongen GP, Beckers CM, Achekar ID, Zeeman S, Musters RJ, van Hinsbergh VW. Involvement of Rho kinase in endothelial barrier maintenance. Arterioscler Thromb Vasc Biol 2007;27:2332–2339.

Lee YJ, Kang DG, Kim JS, Lee HS. Effect of Buddleja officinalis on highglucose-induced vascular inflammation in human umbilical vein endothelial cells. Exp Biol Med (Maywood) 2008;233:694–700.

Li HL, Peng WH, Cui ST, Lei H, Wei YD, Li WM, et al. Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris. Clin Chem Lab Med 2011;49:1547–1554.

Song J, Kost CK Jr, Martin DS. Androgens potentiate renal vascular responses to angiotensin II via amplification of the Rho kinase signaling pathway. Cardiovasc Res 2006;72:456–463.

Godsland IF, Pavitt D, Okoturo O, Edwards RJ, Rubens MB, Feher MD, et al. Can protein biomarkers provide an index of coronary artery calcification in patients with type 2 diabetes? Atherosclerosis 2010;213:570–572.

Jin C, Lu L, Zhang RY, Zhang Q, Ding FH, Chen QJ, et al. Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus. Clin Chim Acta 2009;408:45–49.

Shimokawa H, Rashid M. Development of Rho-kinase inhibitors for cardiovascular medicine. Trends Pharmacol Sci 2007;28:296–302.

Kolavennu V, Zeng L, Peng H, Wang Y, Danesh FR. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes 2008;57:714–723.

Zhai J, Lin H, Nie Z, Wu J, Canete-Soler R, Schlaepfer WW, et al. Direct interaction of Focal Adhesion Kinase with p190RhoGEF. J Biol Chem 2003;278:24865–24873.

FULL TEXT LINK

More>

浏览量

805

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Tanshinone II A inhibits dendritic cell-mediated adaptive immunity: Potential role in anti-atherosclerotic activity

Effects of tanshinone II A on the myocardial hypertrophy signal transduction system protein kinase B in rats

Protective effect of tanshinone II A on lipopolysaccharide-induced lung injury in rats

Influence of traditional Chinese medicine Qingjieling ( ) on LFA-1-dependent leukocyte adhesion to endothelial cells) on LFA-1-dependent leukocyte adhesion to endothelial cells

Aqueous extracts of Tribulus terrestris protects against oxidized low-density lipoprotein-induced endothelial dysfunction